Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Paul Fisher
Johns Hopkins University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cancer Targeting Systems, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Several CTS-licensed technologies, two of which are owned by VCU, will be further developed in the SPORE. Such technology development within a funded research project gives the appearance of benefiting CTS and its owners.
SPORE in Prostate Cancer
This SPORE is dedicated to improving outcomes from prostate cancer, which affects 1 in 5 to 1 in 6 men in the United States, by delivering new approaches to prostate cancer detection, diagnosis, and treatment. Over the planned 5 years of funding, each of these new approaches, as monitored using aggressive milestones/timelines, should move measurably closer to clinical application and benefit.
Filed on September 25, 2014.
Tell us what you know about Paul Fisher's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Paul Fisher”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | Value cannot be readily determined |
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | $60,000 - $79,999 |
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | Value cannot be readily determined |
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | $60,000 - $79,999 |
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | Value cannot be readily determined |
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | Value cannot be readily determined |
| Paul Fisher | Johns Hopkins University | Conflict of Interest | Cancer Targeting Systems, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.